Research - Kadima Zoran, Center District, Israel
Inflammation is a major risk factor in virtually every significant chronic human disease. InnVentis creates new products and services that enable prevention and cure of chronic diseases by stratifying patients into subgroups responsive to new drugs. The convergence of multi-omics with real-time Big DATA analysis now allows disruptive approaches to decipher human complexity. This creates an opportunity to develop new specific and personalized products & services under the emerging paradigm PRECISION MEDICINE. Under this paradigm InnVentis was specifically designed and tailored to address pressing problems of the biopharmaceutical/nutraceutical industries
Apache
Google Font API